# Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

> **NCT02222545** · PHASE2 · COMPLETED · sponsor: **Omeros Corporation** · enrollment: 58 (actual)

## Conditions studied

- Thrombotic Microangiopathies

## Interventions

- **BIOLOGICAL:** OMS721

## Key facts

- **NCT ID:** NCT02222545
- **Lead sponsor:** Omeros Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-02
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-08-11
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02222545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02222545, "Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02222545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*